Drug Profile
Agalsidase beta biosimilar - ISU Abxis
Alternative Names: Fabagal; ISU-303Latest Information Update: 17 Oct 2023
Price :
$50
*
At a glance
- Originator ISU Abxis
- Class Galactosidases; Glycoproteins; Isoenzymes; Recombinant proteins
- Mechanism of Action Alpha-galactosidase replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Fabry's disease